🔴 Moderna is trading 3.04% down today after profit-taking following recent rally

MRNA is trading at $39.34, down 3.04%, representing profit-taking after the dramatic 17.02% surge following upbeat preliminary 2025 results and 2026 guidance.

• The decline follows a 17.02% surge on January 13, driven by positive guidance announced at the J.P. Morgan Healthcare Conference.
• Despite the pullback, the stock remains up significantly over the past week.
• Broader market strength (NASDAQ +0.69%, S&P 500 +0.48%) suggests the decline is sector-specific rather than market-driven.